Angiography News and Research

RSS

Study questions frequency of heart angiograms

A recent study raises questions about the frequency of doctors' use of elective heart angiograms, which showed no disease in almost 40 percent of patients. BusinessWeek reports: "Doctors may be sending patients too quickly for elective angiograms to detect heart disease, exposing them to radiation and driving up U.S. health-care costs, a study suggests.

12 Mar 2010

ACIST Medical Systems to provide CVi contrast injection system to HealthTrust Purchasing Group

ACIST Medical Systems, Inc., a world-leading provider of contrast-delivery systems for cardiology and radiology imaging, announced today that HealthTrust Purchasing Group, LP (HealthTrust), Brentwood, Tenn., one of the leading health care group purchasing organizations, has awarded the company a three-year contract, effective December 1, 2009, for ACIST cardiovascular injection technology, the ACIST | CVi® Contrast Delivery System.

9 Mar 2010

Atherotech to exhibit VAP Cholesterol Test at ACC 2010

Atherotech Inc. today announced it will be presenting research in two poster sessions and exhibiting its VAP® Cholesterol Test in booth #1311 at the American College of Cardiology (ACC) 59th Annual Scientific Session Exposition. The annual meeting takes place March 14-16, 2010, at the Georgia World Congress Center in Atlanta.

9 Mar 2010

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Rcadia Medical Imaging today announced that it has received a CE Mark for the COR Analyzer® System, its proprietary software that helps identify patients with significant CAD (Coronary Artery Disease) by a fully automatic analysis of coronary CT angiography (cCTA) studies. The CE Mark allows the company to market the system in the European Union and other countries that accept the CE Mark registration. The COR Analyzer is marketed in the U.S. under 510(k) clearance and Rcadia was named 2009 Best New Radiology Vendor by AuntMinnie.com.

8 Mar 2010

Evaluating asymptomatic diabetics for CHD: Speckle Tracking by Echo ultrasound substudy sponsored

Cardiovascular death is the most common cause of mortality among Type 2 diabetics and claims the lives of millions each year, with many diabetics experiencing their first “symptom” as a heart attack or sudden death. Understanding that diabetics are at high risk for Coronary Heart Disease (CHD) and that many with the disease are asymptomatic, Toshiba America Medical Systems, Inc., has sponsored Speckle Tracking by Echo, a faCTor64 substudy using Toshiba’s Wall Motion Tracking ultrasound technology.

8 Mar 2010

Endoscopic and surgical treatment of GV bleeding: MDCTPV could provide valuable references

Gastric varices (GV) are an important complication of portal hypertension. As an almost atraumatic method, computed tomography (CT) angiography has been used widely to show the portal vein system. However, the collateral circulation of GV in different locations has been reported only rarely.

6 Mar 2010

RMR can non-invasively, quickly and accurately detect presence of sCAD

Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.

3 Mar 2010

FiberNet EPS has 97.5% success rate in patients undergoing CAS: EPIC study

A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.

1 Mar 2010

Carotid artery stenting and carotid endarterectomy equally safe and effective for people at risk for stroke

Carotid artery stenting, a less invasive alternative to surgery on the carotid artery (carotid endarterectomy), is equally safe and effective for people at risk for stroke as carotid endarterectomy, according to a major new study presented today at the 2010 International Stroke Conference in San Antonio, Texas.

26 Feb 2010

Resverlogix commences enrollment in RVX-208 Phase 2 clinical trial for atherosclerosis in ACS patients

Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.

26 Feb 2010

Little Company of Mary installs Toshiba America Medical Systems' Vantage Atlas MR system

In response to concern over gadolinium-based contrast agents, Little Company of Mary, a not-for-profit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients. To accomplish this, the facility installed Toshiba America Medical Systems, Inc.’s Vantage Atlas® MR system and utilized the full suite of proprietary contrast-free MRA techniques.

25 Feb 2010

PressureWire Aeris technology now available to hospitals using Horizon Cardiology Hemo solution

St. Jude Medical, Inc. announced today its wireless PressureWire™ Aeris technology, which aids in the diagnosis and treatment of coronary artery blockages by measuring Fractional Flow Reserve (FFR), will now be available to hospitals using the McKesson Horizon Cardiology Hemo™ solution.

24 Feb 2010

New cardiac imaging technique reduces radiation exposure compared to standard helical scan

In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.

23 Feb 2010

Revised and updated edition of Toole's Cerebrovascular Disorders textbook now available

Since it was published more than 40 years ago, Toole's Cerebrovascular Disorders has been a standard textbook for the prevention, diagnosis and treatment of strokes.

18 Feb 2010

NIA develops CardiacConnections program to drive better patient outcomes

Cardiovascular-related examinations account for more than one in three noninvasive diagnostic imaging procedures in the United States. In response to this growing trend and concerns about clinical appropriateness and affordability, National Imaging Associates, a subsidiary of Magellan Health Services, Inc., developed CardiacConnections™, a cardiac management program designed for the benefit of patients, providers, payers, and the health care industry.

18 Feb 2010

Educational event: SCAI highlights gender and racial disparities in treating cardiovascular disease

The Society for Cardiovascular Angiography and Interventions (SCAI) today announced an educational event for the public highlighting the gender and racial disparities in the prevention and treatment of cardiovascular disease. The "Know What Counts" educational program titled, "The Path to Health Care Equity: Identifying and Solving Racial, Ethnic, and Gender Disparities in Health Care in the New Century," will feature a distinguished physician panel, along with a keynote address by U.S. Senator Ben Cardin.

17 Feb 2010

FDA grants marketing clearance for Volcano's Eagle Eye Platinum digital IVUS catheter

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.

9 Feb 2010

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.

9 Feb 2010

Vanderbilt Heart and Vascular Institute offers new blood test to predict heart disease

Just in time for American Heart Month, Vanderbilt Heart and Vascular Institute is offering a new blood test that can predict if a patient is at high risk for heart disease. Vanderbilt is among the first institutions in the country, and the only one in Tennessee, to offer this test.

5 Feb 2010

New report illustrates why cardiovascular disease is under-recognized and under-treated in women

Today, the Society for Cardiovascular Angiography and Interventions (SCAI) launched "WINHeart -- Score a WIN for Women," an initiative that raises awareness surrounding gender-based disparities in the diagnosis, treatment and survival of women with cardiovascular disease (CVD).

28 Jan 2010